Intravascular stents, currently in experimental human use for recurrent arterial stenosis, are plagued by subacute thrombosis. As a therapeutic approach to stent-related thrombosis, we and others have suggested coating stents with endothelial cells before implantation. In a previous study we demonstrated the feasibility of coating stents with endothelial cells that were genetically modified to secrete large amounts of human tissue plasminogen activator. In the present study we attempted both to develop a clinically applicable protocol for stent seeding and to test whether seeded cells would remain adherent to stents after exposure to pulsatile flow. Endothelial cells were harvested from the saphenous veins of sheep with survival of the donor animals. Harvested cells were transduced with a retroviral vector containing a marker gene and seeded onto cathetermounted stents under sterile conditions. Scanning electron microscopy revealed complete coverage of the stent surfaces by seeded cells. Stents were expanded and exposed to pulsatile flow in vitro. Substantial cell retention was observed on the lateral stent surfaces by light microscopy and scanning electron microscopy; fewer cells were seen on the luminal and abluminal surfaces. Removal of seeded cells from flow-exposed stents by trypsin digestion resulted in the recovery of approximately 70%Yo of the seeded cells. These cells were viable and healthy as judged by their ability to proliferate to confluence with the same kinetics as control (non-flow-exposed) cells tion of the balloon catheter-mounted stents under sterile conditions ( Figure 1 ). With this apparatus, catheter-mounted stents were incubated in an aqueous solution of 100 ,g/ml human fibronectin (Collaborative Research Inc., Bedford, Mass.) for 15 minutes at 37°C. Transduced endothelial cells, freshly harvested from culture dishes by trypsin digestion, were counted in a hemacytometer and suspended in complete culture medium (medium 199 with 20% fetal calf serum) at a concentration of 1.25 x 106 cells per milliliter. The fibronectin solution was aspirated and replaced with 1 ml cell suspension, and the apparatus was returned to the incubator (5% C02, 37°C). The tube containing the cell suspension was rotated 1800 about the longitudinal axis of the catheter every 10 minutes for 2 hours. The apparatus was then left in the incubator for 72 hours, with replacement of culture medium every 24 hours.
Cell Adherence to Stent Surfaces
We evaluated the coverage of stent surfaces with seeded cells under three conditions: 1) after the 72-hour incubation but without balloon expansion, 2) after incubation and balloon expansion in 5-mmdiameter plastic tubing (Tygon, Akron, Ohio) but without exposure to flow, and 3) after expansion in plastic tubing and exposure to pulsatile flow for 2 hours. In the latter two cases, stents were expanded at a balloon pressure of 6 atm by using a standard angioplasty inflation device.
Cell adherence and retention to the stent surfaces were studied by three independent methods: 1) his-pulsatile flow system Additional seeded stents (n=6) were expanded in plastic tubing in the pulsatile flow system and exposed to flow for 2 hours. Assessment of cell retention by X-Gal staining ( Figure 4) and SEM (not shown) revealed a pattern of cell retention similar to that observed with the four stents that were expanded without flow.
Because of both the semiquantitative nature of the light microscopy and SEM techniques for evaluating cell retention and the difficulty of visualizing all stent surfaces with either technique, we attempted to recover cells from the stents with trypsin digestion and count the cells directly. Cells were digested from the surfaces of 12 seeded stents: five unexpanded stents, four stents that had been expanded in plastic tubing without flow, and three stents that were expanded and exposed to flow for 2 hours. The results of the cell counts obtained from trypsinization of these 12 stents are summarized in Figure 5 .
Approximately 10% of the seeded cells were lost on expansion and another 20% were lost during the 2 hours of flow.
As a further verification of the viability and proliferative potential of the seeded cells, we cultured the cells that were recovered by trypsin digestion of seeded stents. Cultures were established from nine of the above-mentioned 12 stents and from an additional four seeded stents (from which cells were cultured without counting). Cells recovered from four seeded, unexpanded stents proliferated to cover a 15-mm-diameter tissue culture dish in 6.6+2.3 days (range, 5.5-10 days). Cells recovered from four expanded stents (not exposed to flow) reached confluence in 8.2+2.7 days (range, 4-10 days), and cells recovered from five expanded, flow-exposed stents achieved confluence in 7.6+2.0 days (range, 5.5-10 days). The nearly identical times to confluence correlated well with the very similar numbers of cells that were counted after trypsinization of stents in each of the three groups of stents illustrated in Figure 5 . In all cases, cells recovered from the stents retained their typical morphology and contact inhibition ( Figure 6 ).
Discussion
We developed and tested a protocol for the seeding of intravascular stents with autologous, gene-engineered endothelial cells. The current protocol, in con- In this context, the use of the B2NSt vector,9 which has a titer of approximately 5x105 colony forming units/ml compared with 5 x 104 cfu/ml for LBgSN, provided a large number of transduced cells 3-4 weeks earlier than did LBgSN (data not shown).
A delay of 2-3 months from cell harvest to stent deployment imposes a significant limitation on the use of seeded stents in acute clinical circumstances. As an alternative to this substantial delay, cells could be harvested from a patient under elective circumstances and transduced, and an appropriate number of cells frozen until needed. Once thawed and reestablished in culture (a process that requires only several hours), the time to seeding and stent deployment should be less than a week. as judged from the experience described herein. A 1-week delay is quite compatible with elective stent placement (e.g., in the treatment of restenosis). A recent report suggests that coronary stenting may in fact be more useful in the treatment of the more subacute process of restenosis than in more acute coronary syndromes such as infarction and thrombosis. 4 Still, the prophylactic C FIGURE 6. Endothelial cells harvested from seeded stents are viable, morphologically intact, and retain proliferative capacity. Panel A: Cells plated in a tissue culture dish at the same time and density as cells that were seeded onto a stent. Photograph was taken 5 days after plating. Panel B: Cells recovered from a stent that was expanded in plastic tubing. Photograph was taken 5 days after cell recovery andplating. Panel C: Cells recoveredfrom a stent that was expanded and exposed to flow. Photograph was taken harvesting and transduction of the endothelial cells of large numbers of patients is likely to be both cumbersome and expensive. If in vivo studies in animal models indicate a potential clinical role for seeded stents, the development of more expeditious harvest and transduction protocols will be a high priority.
Endothelial cells from one of the three sheep could not be transduced with the LBgSN vector, suggesting that retroviral vector-mediated gene transfer may not be uniformly successful. The cells of this particular sheep could, however, be transduced with the higher titer B2NSt vector (data not shown).9 The reason for the repeated failure to transduce with LBgSN is not clear; however, our overall experience with sheep endothelial cells9,19 suggests that failure to transduce is uncommon. Initial experience with human endothelial cells in our laboratory20 and others21 suggests that retroviral vector-mediated gene transfer will also be reliable when directed at human endothelial cells.
We were initially concerned that the luminal surface of the stents might not be accessible to cells when seeding was performed after the stents were mounted on a balloon catheter. Luminal coverage of the seeded, unexpanded stents could not be evaluated ( Figure 3 ). Expanded stents, however, in which the luminal surface could be seen, did have cell coverage of large areas of the luminal stent surface (Figure 4 ). These observations demonstrate that all surfaces of catheter-mounted stents can be seeded and that luminal cells can survive balloon expansion and exposure to flow.
Large variability existed among the three independent methods we used for evaluating cell retention after expansion and flow. SEM showed the fewest cells, with X-Gal staining revealing substantially more retained cells. Harvest of cells from the stents by trypsin digestion resulted in the highest estimate of cell retention. We attribute the low number of cells seen by SEM to the artifactual loss of cells during specimen processing. Visualization of X-Galstained cells under the dissecting microscope is difficult because of the existence of multiple stent surfaces in different, nonparallel focal 
